Underdevelopment of the second kidney

Q17_UNDERDEVELOPMENT_OF_THE_SECOND_KIDNEY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q60.3 Cause of death: ICD-10 — Q60.3 2 out of 7 registries used, show all original rules.	49
4. Check minimum number of events None	49
5. Include endpoints None	49
6. Filter based on genotype QC (FinnGen only)	48

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

NAME	Q17_UNDERDEVELOPMENT_OF_THE_SECOND_KIDNEY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q603
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q603
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Underdevelopment of the second kidney based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	48	18	30
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	29.04	18.75	35.21

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018418) pH of Serum or Plasma

8.95

13.00

16.5

3.5

7.37

7.40

1.69

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

17.22

7.30

14.6

1.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

150

4.67

6.29

12.2

3.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

8.06

6.27

4.1

4.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

11.42

6.16

1.7

2.0

—

(1616796) Gas panel - Central venous blood

12.18

5.84

16.3

2.5

—

(3027315) Oxygen [Partial pressure] in Blood

15.34

5.84

13.6

4.9

9.03

9.89

kpa

—

(3013290) Carbon dioxide [Partial pressure] in Blood

15.34

5.84

13.6

4.9

4.69

4.99

kpa

—

(3021901) Oxygen saturation in Capillary blood

15.34

5.84

8.3

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

18.68

5.62

2.0

3.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

9.09

5.50

2.0

1.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

8.51

5.30

2.5

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

11.90

5.27

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

7.19

5.15

7.2

3.6

0.00

0.14

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

10.70

5.02

8.9

1.7

19.98

23.10

mmol/l

—

(3025159) Blasts/100 leukocytes in Blood

6.85

4.99

7.2

3.3

0.00

0.13

—

(3017181) Myelocytes/100 leukocytes in Blood

6.54

4.84

7.2

3.3

0.14

0.33

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

188

4.02

4.82

21.5

11.1

1.23

1.22

mmol/l

0.25

169

(3042936) Bacteria identified in Isolate by Culture

4.38

4.59

2.0

3.5

—

(36304419) Bacteria [Presence] in Urine

130

3.40

4.26

11.9

3.1

—

(3000991) Gas panel - Venous blood

3.76

4.10

7.4

9.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

116

3.10

3.63

10.3

11.4

1.26

1.32

inr

0.13

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3.35

3.60

11.1

10.7

21.91

24.57

mmol/l

2.62

(3048929) Epstein Barr virus Ab [Presence] in Serum

4.75

3.56

1.9

1.5

—

(3023368) Bacteria identified in Blood by Culture

3.15

3.46

6.8

5.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

188

3.02

3.34

10.6

4.3

0.00

estimate

-0.00

(3026008) Bacteria identified in Urine by Culture

3.00

3.33

3.1

2.5

—

(3009261) Glucose [Presence] in Urine by Test strip

190

2.97

3.24

9.9

3.0

0.00

estimate

—

(3024354) Oxygen [Partial pressure] in Venous blood

3.29

3.24

5.7

7.8

5.42

5.26

kpa

0.10

(3035350) Ketones [Presence] in Urine by Test strip

191

2.95

3.20

10.0

3.0

0.00

estimate

-0.00

(3029937) Albumin [Presence] in Urine by Test strip

103

2.82

2.99

13.8

3.1

0.00

estimate

—

(40761536) Microorganisms panel - Urine sediment

4.21

2.99

21.0

3.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

7.40

2.96

1.0

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3.05

2.88

7.1

7.5

5.48

5.58

kpa

0.26

(3002032) Base excess in Venous blood by calculation

3.05

2.88

7.1

7.5

0.66

0.53

mmol/l

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

5.63

2.84

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2.76

2.83

13.7

2.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3.04

2.74

7.4

7.2

1.06

2.00

mmol/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

6.04

2.62

1.0

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3.04

2.62

6.4

8.4

22.25

23.10

mmol/l

0.62

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

7.78

2.61

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

5.53

2.48

1.5

1.9

—

(3045414) Leukocytes [Presence] in Urine

5.53

2.48

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

139

2.42

2.33

12.2

2.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

255

2.55

2.18

12.5

3.7

—

(3003694) ABO and Rh group [Type] in Blood

102

2.41

2.15

1.8

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2.92

1.92

1.9

5.3

217.67

408.17

u/l

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3.64

1.81

14.0

2.6

0.02

0.12

e6/l

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4.15

1.76

3.2

52.4

—

(3016502) Oxygen saturation in Arterial blood

3.09

1.72

2.7

29.1

88.67

96.33

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.49

1.65

1.6

2.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3.27

1.63

3.0

34.1

102.50

127.35

g/l

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.44

1.58

1.4

2.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3.58

1.56

6.8

2.3

46.62

68.59

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

100

2.07

1.48

2.5

3.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3.35

1.47

1.2

3.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2.64

1.45

2.6

25.3

13.20

14.71

kpa

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2.64

1.45

2.6

25.2

5.91

5.09

kpa

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2.10

1.43

3.5

1.8

—

(3022621) pH of Urine by Test strip

2.83

1.41

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

0.00

1.41

0.0

3.2

—

29.88

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3.15

1.39

2.2

12.6

89.54

94.55

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2.70

1.35

2.2

4.6

63.23

65.83

g/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.70

1.35

2.0

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.53

1.34

1.6

1.7

—

(1761868) Lipid panel - Serum or Plasma

112

1.96

1.33

5.9

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

147

1.90

1.32

2.9

3.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.16

1.32

3.8

1.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2.97

1.32

2.4

11.9

0.70

0.74

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2.97

1.32

2.4

11.9

1.28

1.56

—

(40768804) Tissue Pathology biopsy report

119

0.44

1.13

1.3

1.9

—

(3025941) Bacteria identified in Stool by Culture

2.53

1.12

2.0

1.2

—

(4035726) Immunohistochemistry procedure

2.23

1.08

1.7

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2.16

1.05

2.1

3.1

6.67

8.47

g/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.16

1.05

1.4

1.8

—

(3002256) Pathology report gross observation

2.10

1.02

1.4

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.10

1.02

1.4

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.96

1.00

2.2

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

123

0.50

0.94

1.4

1.6

—

(3003396) Base excess in Arterial blood by calculation

2.21

0.93

3.0

25.3

2.72

0.47

mmol/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

109

1.69

0.85

3.6

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.81

0.0

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.81

0.0

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

105

1.62

0.71

3.4

2.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

208

1.53

0.70

11.2

8.4

5.80

6.47

mmol/l

1.42

193

(3023103) Potassium [Moles/volume] in Serum or Plasma

378

1.78

0.68

35.7

15.9

4.10

3.96

mmol/l

1.67

366

(3019550) Sodium [Moles/volume] in Serum or Plasma

377

1.80

0.68

34.0

15.8

139.52

139.64

mmol/l

0.16

366

(3022145) Colonoscopy Study observation

1.80

0.65

1.0

1.2

—

(3022313) Gas panel - Capillary blood

1.68

0.64

5.8

7.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

0.00

0.61

0.0

2.2

—

5.88

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.00

0.61

0.0

4.7

—

19.07

—

(3019225) pH of Specimen

0.00

0.61

0.0

4.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.76

0.59

9.5

9.1

105.17

105.06

mmol/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.60

0.56

2.2

3.0

—

(40761511) CBC panel - Blood by Automated count

409

1.74

0.51

26.0

11.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

302

1.41

0.44

37.7

11.5

54.23

91.22

ml/min/173m2

5.33

231

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.42

0.0

1.8

—

176.60

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.44

0.42

4.6

4.2

14118.67

1286.20

ng/l

—

(3022096) Basophils/100 leukocytes in Blood

203

1.36

0.41

11.5

7.7

0.42

0.71

2.00

195

(40760892) CBC W Ordered Manual Differential panel - Blood

203

1.36

0.41

15.0

7.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.40

0.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

4.80

—

(3019198) Lymphocytes [#/volume] in Blood

226

1.32

0.36

10.7

7.6

1.88

2.16

e9/l

0.87

198

(3006504) Eosinophils/100 leukocytes in Blood

208

1.30

0.33

11.5

7.5

2.02

3.13

2.31

199

(3019069) Monocytes/100 leukocytes in Blood

209

1.29

0.32

11.5

7.7

8.60

8.49

0.04

203

(3044889) 12 lead EKG panel

220

1.28

0.30

4.8

2.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

346

0.78

0.27

3.4

3.5

—

(3018010) Neutrophils/100 leukocytes in Blood

214

1.24

0.24

10.5

7.2

56.63

53.09

0.69

209

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.21

0.22

1.6

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

6.3

—

3.54

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

4.2

—

3.52

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

4.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

4.2

—

7.60

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.21

0.0

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

2.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.0

—

18.55

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.21

0.0

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

0.00

0.20

0.0

1.4

—

4.71

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.20

0.0

1.1

—

(40768443) Skin Pathology biopsy report

0.00

0.20

0.0

1.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

217

1.21

0.20

11.6

7.4

29.37

32.34

0.55

212

(40758558) Short blood count panel - Blood

129

0.81

0.17

10.5

8.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.73

0.17

1.8

1.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

405

1.26

0.16

31.0

12.7

12.36

22.37

mg/l

2.65

292

(3007164) IgA [Mass/volume] in Serum or Plasma

122

1.21

0.16

1.1

1.5

1.34

1.77

g/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

318

0.93

0.03

7.4

3.7

5.47

5.83

mmol/l

1.43

296

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3013512) EKG study

0.93

-0.00

2.8

2.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

0.00

-0.00

0.0

3.8

—

10.89

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

5.0

—

0.00

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

0.00

-0.00

0.0

4.0

—

27.13

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

1.7

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

-0.00

0.0

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

-0.00

0.0

3.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

-0.00

0.0

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

3.71

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

139.58

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

4.6

—

2.81

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.2

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

91.40

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

4.5

—

0.13

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

4.1

—

9.73

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

-0.00

0.0

3.8

—

571.25

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.9

—

25.43

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

-0.00

0.0

1.7

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

-0.00

0.0

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

4.5

—

39.79

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

3.98

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

11.00

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

5.0

—

0.00

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40768800) Prostate Pathology biopsy report

0.00

-0.00

0.0

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

4.0

—

36.24

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

0.00

-0.00

0.0

3.7

—

64.56

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

1.54

—

(3006245) CD3-CD19+ cells/100 cells in Blood

0.00

-0.00

0.0

4.2

—

14.67

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

3.8

—

(3023419) Bacteria identified in Sputum by Culture

0.00

-0.00

0.0

4.4

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

169.60

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

4.5

—

0.00

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.0

—

1.02

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.4

—

(4034850) Laboratory test

0.00

-0.00

0.0

7.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

3.10

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

3.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3028433) Virus identified in Specimen by Culture

0.00

-0.00

0.0

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_UNDERDEVELOPMENT_OF_THE_SECOND_KIDNEY – Underdevelopment of the second kidney

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Underdevelopment of the second kidney

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints